Bas Peters

3.5k citations
38 papers · 464 · h-index 15

Impact in

  • Pharmacology top 10%
    • Pharmacogenetics and Drug Metabolism
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies

Papers in

    • Lung Cancer Treatments and Mutations 16
    • Lung Cancer Diagnosis and Treatment 9
    • Cancer Immunotherapy and Biomarkers 7
    • Lung Cancer Research Studies 6
    • Colorectal Cancer Treatments and Studies 5

Bas Peters

33 papers receiving 461 citations

Peers

Bas Peters
Comparison fields: 5 of 71
  • Pharmacology 57
  • Oncology 167
  • Cancer Research 69
  • Pulmonary and Respiratory Medicine 149
  • Surgery 142
Replace Felipe Melo Cruz with:
Felipe Melo Cruz Brazil
Jennie Chang United States
Yufei Feng China
Paul Gougis France
Amy Damask United States
Nathalie Letarte Canada
Jared Spitz United States
Solomon Moshkevich United States
Eisei Oda Japan
Devron R. Shah United Kingdom
Bas Peters relative to Felipe Melo Cruz Brazil Felipe Melo Cruz's profile →
Citations per field
00.5×1.5×2.2×
Felipe Melo Cruz · 1×
Citations per year

Countries citing papers authored by Bas Peters

Since Specialization
Citations

This map shows the geographic impact of Bas Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Peters more than expected).

Fields of papers citing papers by Bas Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Peters. The network helps show where Bas Peters may publish in the future.

Co-authors

The 25 scholars most cited alongside Bas Peters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bas Peters Line = papers co-authored together Bas Peters links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202167
2 201842
3 201038
4 201136
5 201335
6 202119
7 201319
8 201018
9 201717
10 200917
11 200914
12 201814
13 202014
14 200914
15 202114
16 201811
17 200811
18 20109
19 20238
20 20197

About Bas Peters

Bas Peters is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pharmacology and Molecular Biology, having authored 38 papers that have together received 464 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lipoproteins and Cardiovascular Health (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pharmacology (57 citations), Oncology (167 citations), Cancer Research (69 citations), Pulmonary and Respiratory Medicine (149 citations) and Surgery (142 citations). Bas Peters has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Olaf H. Klungel, Anke H. Maitland‐van der Zee, Franz M.N.H. Schramel, E.M.W. van de Garde, Anthonius de Boer, Bruno H. Stricker, Elisabeth A. Kastelijn, Harry J.M. Groen, Andréi S. Rodin and Cornelia M. van Duijn. Their work appears in journals such as Pharmacogenetics and Genomics, Scientific Reports, Clinical Lung Cancer, Pharmacogenomics and Anticancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact